SHEMESH SHAY (Chief Development Officer) purchased 0.0% of their position (670.00 shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $7.2K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/17/2023ACC: 0001104659-23-033594
Officer· Chief Development Officer
Since Feb 2022
+670.00
Net shares
Net buyer
$7.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
670.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+670.00
Price / share
$10.71
Trade value
$7.18K
% of position
0.0%
3/15/2023
1.36M→1.36M
Total
Net shares
+670.00
Net value
$7.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2023 | P · Purchase | +670.00 | $10.71 | $7.18K | 0.0% | 1.36M | 1.36M |
| Total | +670.00 | $7.18K | ||||||
Derivative Transactions0
No derivative transactions reported